NKTR

NASDAQStock

Nektar Therapeutics

$69.22-4.11 (-5.60%)

52-Week Range

$7.36
$73.86

Key Stats

Market Cap

1.4B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.23

Volume

494.0K

Avg Volume

993.6K

Performance

1M

+25.64%

3M

+28.63%

6M

+43.56%

YTD

+62.05%

1Y

+472.03%

3Y

+290.89%

5Y

-79.15%

Price Chart

ETF Exposure

NKTR is held by 24 ETFs

ETFFund NameWeight
CNCRLoncar Cancer Immunotherapy ETF3.37%
XPHState Street SPDR S&P Pharmaceuticals ETF2.42%
BBCVirtus Biotech Clinical Trials ETF0.98%
IHEiShares U.S. Pharmaceuticals ETF0.51%
PILLDirexion Daily Pharmaceutical & Medical Bull 3X ETF0.48%
PRFZInvesco RAFI US 1500 Small-Mid ETF0.16%
DMRMDeltaShares S&P 400 Managed Risk ETF0.13%
KBFRInnovator U.S. Small Cap Managed 10 Buffer ETF0.09%
SCHASchwab U.S. Small-Cap ETF0.05%
ISCViShares Morningstar Small-Cap Value ETF0.03%
JKLiShares Morningstar Small-Cap Value ETF0.03%
ISCBiShares Morningstar Small-Cap ETF0.03%
JKJiShares Morningstar Small-Cap ETF0.03%
ISCGiShares Morningstar Small-Cap Growth ETF0.03%
JKKiShares Morningstar Small-Cap Growth ETF0.03%
FHLCFIDELITY MSCI HEALTH CARE INDEX ETF0.03%
WSMLiShares MSCI World Small-Cap ETF0.01%
VXFVanguard Extended Market ETF0.01%
VHTVanguard Health Care ETF0.01%
ONEQFIDELITY NASDAQ COMPOSITE INDEX ETF0.00%
SCHBSchwab U.S. Broad Market ETF0.00%
ITOTiShares Core S&P Total U.S. Stock Market ETF0.00%
VTIVanguard Total Stock Market ETF0.00%
AVTMAvantis Total Equity Markets ETF 10.00%

About NKTR ETF Exposure

Nektar Therapeutics (NKTR) is held by 24 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.4B, NKTR is a widely held institutional stock. The stock currently trades at $69.22. Investors can gain exposure to NKTR through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold NKTR, sorted by portfolio weight.